Generic drugs saved the U.S. healthcare system $3.4 trillion from 2015-2024. Learn how Hatch-Waxman, biosimilars, and market competition drive these massive savings and what challenges remain.
Jun, 8 2026
Aug, 9 2025
Sep, 4 2023
Jul, 24 2025
Feb, 26 2026